CVS Group
CVSG · Main Market · Health Care · mcap £790m · 1183.0p
Answered by AI only from CVSG’s own announcements, every statement linked to its source. Free with an account – no password, just a link. Not investment advice.
- Market cap
- £804m
- EV
- £1.0bn
- Net debt
- £196m
- Revenue
- £713m
- EBITDA
- £94.6m
- Shares
- 68.0m −3.9%
| FY26 | Latest | |
|---|---|---|
| Shares m | 70.0 | 68.0 |
| Change | −2.9% | |
| Why | buybacks |
Count in force at each financial year end (excl. treasury shares), from the company's voting rights notices or its results. Red: dilution above 5% a year; green: share count falling. * adjusted for a consolidation or split.
-
30 Sep
TVR & Confirmation of Dividend Dates
Total Voting Rights & Confirmation of Dividend Dates
-
24 Sep
Final Results
Final results for the year ended 30 June 2026
-
23 Jul
Full year trading update
FY26 Adjusted EBITDA3 in line with market consensus
-
26 May
Changes to NEDs' Responsibilities
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
-
26 May
Commencement of Share Buyback Programme
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Company filings. Not investment advice.